Benjamin F. Edwards & Company »

Crispr Therapeutics shares owned by Benjamin F. Edwards & Company

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Benjamin F. Edwards & Company from 13F filings

Historical chart of Benjamin F. Edwards & Company investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Benjamin F. Edwards & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Benjamin F. Edwards & Company

Quarter filed Position value Share count Share price at filing
2024-06-30 $1.8M 34k 54.00
2024-03-31 $45k 663 67.50
2023-12-31 $6.0k 100 60.00
2023-09-30 $5.0k 100 50.00
2023-06-30 $6.0k 100 60.00
2023-03-31 $5.0k 100 50.00
2022-12-31 $4.0k 100 40.00
2022-09-30 $7.0k 100 70.00
2022-06-30 $6.0k 100 60.00
2022-03-31 $6.0k 100 60.00
2021-12-31 $8.0k 100 80.00
2021-09-30 $11k 100 110.00
2021-06-30 $16k 100 160.00
2021-03-31 $24k 200 120.00
2019-09-30 $16k 400 40.00
2019-06-30 $58k 1.2k 47.27
2019-03-31 $44k 1.2k 35.86
2018-12-31 $46k 1.6k 28.27
2018-09-30 $37k 827 44.74
2018-06-30 $28k 477 58.70
2018-03-31 $5.0k 100 50.00
2017-12-31 $2.0k 100 20.00